|
|
|
|
 |
LOS ANGELES--- CytoDyn Appoints Dr. Nader Z. Pourhassan Chief Operating Officer |
| 5/19/2008 @ 8:30 AM
print this article -
email to a friend -
join our eNewsletter
|
 |
CytoDyn, Inc. (Pink Sheets:CYDY) has appointed Nader Z. Pourhassan, Ph.D., as its Chief Operating Office. Dr. Pourhassan was born in Tehran in 1963, immigrated to the United States in 1977, and became a U.S. citizen in 1991. He received his Bachelor of Science from Utah State University in 1985, his Master of Science from Brigham Young in 1990, and his Ph.D. from the University of Utah in 1998. After being an instructor in engineering and mathematics, he became a successful businessman. After Dr. Pourhassan became aware of the economic and humanitarian potential of Cytolin — CytoDyn’s novel immune therapy for treating HIV/AIDS, he made it his priority to bring his considerable scientific, marketing, and management skills to our Company.
Development of Cytolin had been delayed after the CEO of Amerimmune Pharmaceuticals, the previous licensee of the technology, made an effort to take that company's assets as his personal property. Based on an opportunity offered by one of CytoDyn’s largest shareholders, the company used the time needed to recover Cytolin to pursue development of a novel influenza vaccine. However, because the vaccine was pre-clinical, the economic downturn favored abandoning that project in favor of Cytolin , a first-in-class product for which there is considerable human experience, as reported by CBS-TV News. The Company now intends to pursue a Phase II study of Cytolin as salvage therapy for HIV/AIDS.
About Cytolin
HIV infects other species, such as chimpanzees. But only humans get sick from HIV infection. In the early 1990s, several teams of university-based scientists reported in the peer-review literature that this is because of a flaw in the human immune system. Cytolin , a monoclonal antibody, is designed to correct that flaw. This is different from "reconstituting" the immune system, which can make patients sick ("immune reconstitution syndrome"). With the human immune system working better, we would expect it to do a better job of controlling HIV infection, as suggested by the preliminary results from a Phase I(b)/II(a) clinical trial. Because a properly functioning immune system should control any strain of HIV, Cytolin is intended to help patients infected with drug-resistant strains of HIV, and might even prevent drug resistance from developing when used in combination with antiretroviral drugs. |
| Tech People On the Move - California |
|
|
| |
| Friday, August 29, 2008 |
 |
|
EL SEGUNDO--- Internet Brands Appoints Scott Friedman CFO Posted 2:38 PM PST
REDWOOD CITY--- Gary Read, President and CEO of Nimsoft, Appointed to Board of Directors of Scalable Software Posted 8:44 AM PST
SAN DIEGO--- Cadence Pharmaceuticals Appoints Todd Rich, M.D. to its Board of Directors and Names Malcolm Lloyd-Smith as Senior Vice President, Regulatory Affairs and Quality Assurance Posted 8:35 AM PST
SANTA CLARA--- GSI Technology, Inc. Announces New Director Posted 8:24 AM PST
|
| |
| Thursday, August 28, 2008 |
|
|
MILPITAS--- KLA-Tencor Appoints Mark P. Dentinger New Chief Financial Officer Posted 2:56 PM PST
MILPITAS--- President and COO John Kispert to Leave KLA-Tencor Posted 2:55 PM PST
|
| |
| Tuesday, August 26, 2008 |
|
|
LOS ANGELES--- Anodyne Medical Device, Inc. Announces Abbey Daniels as New Chief Executive Officer Posted 3:37 PM PST
SAN DIEGO--- Prometheus Announces New Chief Financial Officer Posted 8:49 AM PST
SAN MATEO--- Quantivo Appoints High-Tech Veterans to Executive Team Posted 8:36 AM PST
|
| |
| Friday, August 22, 2008 |
|
|
SAN DIEGO--- JMAR Technologies Forms Unit for Radiological/Nuclear Detection, Hires Leading Systems Engineer Posted 3:43 PM PST
|
| |
| Thursday, August 21, 2008 |
|
|
SANTA BARBARA--- QAD Announces Departure of Chief Financial Officer Posted 4:04 PM PST
SAN DIEGO--- BakBone Software Appoints New Chief Financial Officer; Steve Martin Joins BakBone from Leap Wireless Posted 3:56 PM PST
SAN LEANDRO--- Alpha Innotech Appoints Michael Henighan Chief Financial Officer Posted 8:41 AM PST
|
| |
| Wednesday, August 20, 2008 |
|
|
SAN DIEGO--- MicroIslet Appoints New CFO Posted 5:40 AM PST
|
| |
| Tuesday, August 19, 2008 |
|
|
CARLSBAD--- NTN Buzztime Appoints Jeff Berg to Board of Directors Posted 3:07 PM PST
MOUNTAIN VIEW--- SumTotal Hires Patricia Lughezzani as Vice President of Global Support Posted 7:55 AM PST
SAN MATEO--- Bruce Pagliuca Named as Senior VP of Operations of M-Factor Posted 7:52 AM PST
SAN DIEGO--- ItherX Pharmaceuticals Appoints Scientific and Clinical Advisory Board for Hepatitis C Antiviral Drugs Posted 7:26 AM PST
|
| |
| Monday, August 18, 2008 |
|
|
SAN DIEGO--- Somaxon Pharmaceuticals Announces the Appointment of Senior Commercial Leadership Posted 4:24 PM PST
SAN RAMON--- Kevin Van Bladel Joins BioVentrix as Vice President of Research and Development Posted 7:33 AM PST
|
|
|
|
|
|
FreshNews.com Jobs Change DAILY
We Have 5,000 + Job Listings! Open Your FREE Account
Employers or Job Searchers Get Started Now! Click Here
|
